128 related articles for article (PubMed ID: 11860745)
1. Inhibition of 11beta-hydroxysteroid dehydrogenase in guinea pig kidney by three bioflavonoids and their interactions with gossypol.
Wang MS; Shi H; Wang KS; Reidenberg MM
Acta Pharmacol Sin; 2002 Jan; 23(1):92-6. PubMed ID: 11860745
[TBL] [Abstract][Full Text] [Related]
2. NAD- and NADP-dependent 11 beta-hydroxysteroid dehydrogenase isoforms in guinea pig kidney with gossypol inhibition.
Wang MS; Lorenzo BJ; Reidenberg MM
Zhongguo Yao Li Xue Bao; 1997 Nov; 18(6):481-5. PubMed ID: 10322899
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of 11 beta-hydroxysteroid dehydrogenase by gossypol and bioflavonoids.
Song D; Lorenzo B; Reidenberg MM
J Lab Clin Med; 1992 Nov; 120(5):792-7. PubMed ID: 1431508
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of 11beta-hydroxysteroid dehydrogenase by bioflavonoids and their interaction with furosemide and gossypol.
Guo J; Reidenberg MM
J Lab Clin Med; 1998 Jul; 132(1):32-8. PubMed ID: 9665369
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of 11 beta-hydroxysteroid dehydrogenase obtained from guinea pig kidney by some bioflavonoids and triterpenoids.
Zhang YD; Wang MS
Zhongguo Yao Li Xue Bao; 1997 May; 18(3):240-4. PubMed ID: 10072942
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of gossypol on corticosteroid 11-beta-hydroxysteroid dehydrogenase from guinea pig kidney: a possible mechanism for causing hypokalemia.
Sang GW; Lorenzo B; Reidenberg MM
J Steroid Biochem Mol Biol; 1991 Aug; 39(2):169-76. PubMed ID: 1888675
[TBL] [Abstract][Full Text] [Related]
7. Grapefruit juice and its flavonoids inhibit 11 beta-hydroxysteroid dehydrogenase.
Lee YS; Lorenzo BJ; Koufis T; Reidenberg MM
Clin Pharmacol Ther; 1996 Jan; 59(1):62-71. PubMed ID: 8549035
[TBL] [Abstract][Full Text] [Related]
8. Correlation between decrease of 11beta-hydroxysteroid dehydrogenase activity and hypokalemia induced by furosemide in rats.
Yao B; Zhang YD; Shen JP
Acta Pharmacol Sin; 2001 Nov; 22(11):991-6. PubMed ID: 11749789
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 11 beta-hydroxysteroid dehydrogenase obtained from guinea pig kidney by furosemide, naringenin and some other compounds.
Zhang YD; Lorenzo B; Reidenberg MM
J Steroid Biochem Mol Biol; 1994 May; 49(1):81-5. PubMed ID: 8003443
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice.
Alberts P; Engblom L; Edling N; Forsgren M; Klingström G; Larsson C; Rönquist-Nii Y; Ohman B; Abrahmsén L
Diabetologia; 2002 Nov; 45(11):1528-32. PubMed ID: 12436336
[TBL] [Abstract][Full Text] [Related]
11. The (+)- and (-)-gossypols potently inhibit human and rat 11beta-hydroxysteroid dehydrogenase type 2.
Chen BB; Lin H; Hu GX; Su Y; Zhou HY; Lian QQ; Cai H; Hardy DO; Gu DY; Ge RS
J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):177-81. PubMed ID: 19150652
[TBL] [Abstract][Full Text] [Related]
12. Furosemide and 11beta-hydroxysteroid dehydrogenase activity, in man.
Palermo M; Armanini D; Shackleton CH; Sorba G; Cossu M; Roitman E; Scaroni C; Delitala G
Exp Clin Endocrinol Diabetes; 2002 Sep; 110(6):272-6. PubMed ID: 12373630
[TBL] [Abstract][Full Text] [Related]
13. Effects of glycyrrhetinic acid derivatives on hepatic and renal 11beta-hydroxysteroid dehydrogenase activities in rats.
Shimoyama Y; Hirabayashi K; Matsumoto H; Sato T; Shibata S; Inoue H
J Pharm Pharmacol; 2003 Jun; 55(6):811-7. PubMed ID: 12841942
[TBL] [Abstract][Full Text] [Related]
14. Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons.
Hult M; Shafqat N; Elleby B; Mitschke D; Svensson S; Forsgren M; Barf T; Vallgårda J; Abrahmsen L; Oppermann U
Mol Cell Endocrinol; 2006 Mar; 248(1-2):26-33. PubMed ID: 16431016
[TBL] [Abstract][Full Text] [Related]
15. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.
Livingstone DE; Walker BR
J Pharmacol Exp Ther; 2003 Apr; 305(1):167-72. PubMed ID: 12649365
[TBL] [Abstract][Full Text] [Related]
16. Comparison of flavonoids and isoflavonoids to inhibit rat and human 11β-hydroxysteroid dehydrogenase 1 and 2.
Zhu Q; Ge F; Dong Y; Sun W; Wang Z; Shan Y; Chen R; Sun J; Ge RS
Steroids; 2018 Apr; 132():25-32. PubMed ID: 29425740
[TBL] [Abstract][Full Text] [Related]
17. Environmental inhibition of 11beta-hydroxysteroid dehydrogenase.
Reidenberg MM
Toxicology; 2000 Apr; 144(1-3):107-11. PubMed ID: 10781877
[TBL] [Abstract][Full Text] [Related]
18. Furosemide inhibits 11beta-hydroxysteroid dehydrogenase type 2.
Fuster D; Escher G; Vogt B; Ackermann D; Dick B; Frey BM; Frey FJ
Endocrinology; 1998 Sep; 139(9):3849-54. PubMed ID: 9724039
[TBL] [Abstract][Full Text] [Related]
19. Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species.
Arampatzis S; Kadereit B; Schuster D; Balazs Z; Schweizer RA; Frey FJ; Langer T; Odermatt A
J Mol Endocrinol; 2005 Aug; 35(1):89-101. PubMed ID: 16087724
[TBL] [Abstract][Full Text] [Related]
20. Gossypol inhibits 5α-reductase 1 and 3α-hydroxysteroid dehydrogenase: Its possible use for the treatment of prostate cancer.
Cao S; Wang G; Ge F; Li X; Zhu Q; Ge RS; Wang Y
Fitoterapia; 2019 Mar; 133():102-108. PubMed ID: 30605780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
